Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
DOI: | 10.1590/s2175-97902022e201095 |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/207450 |
Resumo: | A collaborative physician-pharmacist relationship is a fundamental component of a patient’s primary care. The aim of this study was to investigate the attitude of physicians toward collaborative work with community pharmacists in Sulaimani City, Iraq. A cross sectional design was utilized, and a questionnaire was sent to 60 physicians, of whom 47 completed the questionnaire. A total of 26 (55.3%) physicians stated that they had a history of collaboration with pharmacists in their routine daily work. During/before the treatment process, more than one-third of the physicians “rarely” practiced collaboratively, and one-fifth “never” collaborated. There was little agreement on the community pharmacist’s recommendations; however, after the treatment decision by the physician, a higher degree of agreement was reported, and the number of physicians who were “rarely” or “never” practiced collaboratively decreased to less than 5%. Furthermore, the physicians’ perspective on the pharmacists’ role showed that advising patients on drug administration (85.1%) and preventing drug interactions (76.6%) were the most common duties of the community pharmacists. Physicians agreed on several barriers with respect to collaboration with pharmacists. In conclusion, the physicians’ perspective on the engagement of the community pharmacist in the management of patients was relatively limited. The pharmacist’s recommendation was more accepted after medications were prescribed than before or during decision making on the treatment. |
id |
USP-31_65baf9662d1b682d53276750fc5bc282 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/207450 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
spelling |
Physicians’ attitude towards community pharmacists’ contribution in the treatment decision makingPhysicianAttitudeCollaborationCommunity pharmacistA collaborative physician-pharmacist relationship is a fundamental component of a patient’s primary care. The aim of this study was to investigate the attitude of physicians toward collaborative work with community pharmacists in Sulaimani City, Iraq. A cross sectional design was utilized, and a questionnaire was sent to 60 physicians, of whom 47 completed the questionnaire. A total of 26 (55.3%) physicians stated that they had a history of collaboration with pharmacists in their routine daily work. During/before the treatment process, more than one-third of the physicians “rarely” practiced collaboratively, and one-fifth “never” collaborated. There was little agreement on the community pharmacist’s recommendations; however, after the treatment decision by the physician, a higher degree of agreement was reported, and the number of physicians who were “rarely” or “never” practiced collaboratively decreased to less than 5%. Furthermore, the physicians’ perspective on the pharmacists’ role showed that advising patients on drug administration (85.1%) and preventing drug interactions (76.6%) were the most common duties of the community pharmacists. Physicians agreed on several barriers with respect to collaboration with pharmacists. In conclusion, the physicians’ perspective on the engagement of the community pharmacist in the management of patients was relatively limited. The pharmacist’s recommendation was more accepted after medications were prescribed than before or during decision making on the treatment.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-01-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/20745010.1590/s2175-97902022e201095Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/207450/197580Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRebar Ali MohammedBushra Hassan Marouf2023-08-28T18:55:59Zoai:revistas.usp.br:article/207450Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-08-28T18:55:59Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making |
title |
Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making |
spellingShingle |
Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making Rebar Ali Mohammed Physician Attitude Collaboration Community pharmacist Rebar Ali Mohammed Physician Attitude Collaboration Community pharmacist |
title_short |
Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making |
title_full |
Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making |
title_fullStr |
Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making |
title_full_unstemmed |
Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making |
title_sort |
Physicians’ attitude towards community pharmacists’ contribution in the treatment decision making |
author |
Rebar Ali Mohammed |
author_facet |
Rebar Ali Mohammed Rebar Ali Mohammed Bushra Hassan Marouf Bushra Hassan Marouf |
author_role |
author |
author2 |
Bushra Hassan Marouf |
author2_role |
author |
dc.contributor.author.fl_str_mv |
Rebar Ali Mohammed Bushra Hassan Marouf |
dc.subject.por.fl_str_mv |
Physician Attitude Collaboration Community pharmacist |
topic |
Physician Attitude Collaboration Community pharmacist |
description |
A collaborative physician-pharmacist relationship is a fundamental component of a patient’s primary care. The aim of this study was to investigate the attitude of physicians toward collaborative work with community pharmacists in Sulaimani City, Iraq. A cross sectional design was utilized, and a questionnaire was sent to 60 physicians, of whom 47 completed the questionnaire. A total of 26 (55.3%) physicians stated that they had a history of collaboration with pharmacists in their routine daily work. During/before the treatment process, more than one-third of the physicians “rarely” practiced collaboratively, and one-fifth “never” collaborated. There was little agreement on the community pharmacist’s recommendations; however, after the treatment decision by the physician, a higher degree of agreement was reported, and the number of physicians who were “rarely” or “never” practiced collaboratively decreased to less than 5%. Furthermore, the physicians’ perspective on the pharmacists’ role showed that advising patients on drug administration (85.1%) and preventing drug interactions (76.6%) were the most common duties of the community pharmacists. Physicians agreed on several barriers with respect to collaboration with pharmacists. In conclusion, the physicians’ perspective on the engagement of the community pharmacist in the management of patients was relatively limited. The pharmacist’s recommendation was more accepted after medications were prescribed than before or during decision making on the treatment. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-01-31 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/207450 10.1590/s2175-97902022e201095 |
url |
https://www.revistas.usp.br/bjps/article/view/207450 |
identifier_str_mv |
10.1590/s2175-97902022e201095 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/207450/197580 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022) Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022) Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022) 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1822179249934565376 |
dc.identifier.doi.none.fl_str_mv |
10.1590/s2175-97902022e201095 |